Home › News › Global Pharma

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020.

The company's revenue from operations for the quarter stood at Rs. 5,924.8 crore, witnessed a growth of 8.8% over corresponding previous period.

The company's API revenue for the quarter was at Rs. 780.2 crore, an increase by 6.5% over corresponding previous period.

The company has received final approval for 10 ANDAs in Q1FY21.

Commenting on the company’s performance, N Govindarajan, managing director, Aurobindo Pharma, said: “Amidst challenging times, we have started the financial year by reporting a healthy performance. We have ensured the business continuity without compromising the safety and wellbeing of our employees. We are committed to adhere to quality standards by investing continuously and developing a differentiated product pipeline for a sustainable growth.”

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Darshana

  • Info 1
  • Info 2
  • Info 3
More news about: global pharma | Published by Darshana | August - 13 - 2020 | 155

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology